Instead, mass spectrometry and NMR-based metabolomics studies have provided valuable insights into how cancer cells undergo metabolic switch that consists of glutamine dependent anaplerotic pathways that contributes to citric acid and lipid metabolism through the reversal of the TCA cycle or reductive carboxylation of α-KG by isocitrate dehydrogenase (IDH). This evidence concerns the gene IDH2 and cancer.